Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,942 INR | -1.24% | +3.30% | -5.01% |
Mar. 28 | Alkem Laboratories Forms Subsidiary for Medical Devices Business | MT |
Mar. 28 | Alkem Laboratories Gets 10 Observations from US FDA After Baddi, India Unit Inspection | MT |
Sales 2024 * | 129B 1.55B | Sales 2025 * | 143B 1.71B | Capitalization | 591B 7.09B |
---|---|---|---|---|---|
Net income 2024 * | 18.78B 225M | Net income 2025 * | 21.9B 263M | EV / Sales 2024 * | 4.4 x |
Net cash position 2024 * | 22.27B 267M | Net cash position 2025 * | 27.64B 331M | EV / Sales 2025 * | 3.95 x |
P/E ratio 2024 * |
31.8
x | P/E ratio 2025 * |
27.1
x | Employees | 16,871 |
Yield 2024 * |
0.87% | Yield 2025 * |
0.98% | Free-Float | 36.2% |
Latest transcript on Alkem Laboratories Limited
1 day | -1.24% | ||
1 week | +3.30% | ||
Current month | -3.61% | ||
1 month | -2.02% | ||
3 months | -2.63% | ||
6 months | +38.84% | ||
Current year | -5.01% |
Managers | Title | Age | Since |
---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | - | 23-09-21 |
Nitin Agrawal
DFI | Director of Finance/CFO | - | Jan. 31 |
Manish Narang
CMP | Compliance Officer | 54 | 06-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 84 | 73-08-07 | |
Sandeep Singh
BRD | Director/Board Member | 41 | 13-08-08 |
Director/Board Member | 61 | 87-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 6 M€ | +6.07% | - | |
0.01% | 30 M€ | +5.59% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 4,942 | -1.24% | 427,458 |
24-03-27 | 5,004 | +0.04% | 89,989 |
24-03-26 | 5,002 | +4.43% | 199,779 |
24-03-22 | 4,790 | -0.13% | 138,264 |
24-03-21 | 4,796 | +0.25% | 275,225 |
Delayed Quote NSE India S.E., March 28, 2024 at 08:01 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.01% | 7.18B | |
+33.46% | 701B | |
+26.24% | 571B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-3.61% | 157B |